Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/47726
DC FieldValueLanguage
dc.contributor.authorSantana Rodríguez, Norberto-
dc.contributor.authorGarcía-Herrera, Ricardo-
dc.contributor.authorClavo, Bernardino-
dc.contributor.authorLlontop, Pedro-
dc.contributor.authorPonce-González, Miguel A.-
dc.contributor.authorVillar, Jesús-
dc.contributor.authorLópez-García, Ana-
dc.contributor.authorFiuza Pérez, Mª Dolores-
dc.contributor.authorRodríguez-Bermejo, Juan C.-
dc.contributor.authorGarcía-Castellano, José M.-
dc.contributor.authorMacHín, Rubén P.-
dc.contributor.authorRuíz-Caballero, José A.-
dc.contributor.authorBrito, Yanira-
dc.contributor.authorFernández-Pérez, Leandro-
dc.date.accessioned2018-11-23T15:54:25Z-
dc.date.available2018-11-23T15:54:25Z-
dc.date.issued2012-
dc.identifier.issn1053-2498-
dc.identifier.urihttp://hdl.handle.net/10553/47726-
dc.description.abstractBackground: Chronic rejection (CR) is the main reason for the limited survival rates among lung transplant (LT) recipients. There remains no effective treatment for CR. The aim of this study was to identify new molecular mechanisms involved in CR by using DNA microarray analysis. Methods: We performed 10 left LTs using the microsurgical cuff technique in inbred Sprague-Dawley rats. Lung isograft samples were obtained 3 months after surgery. We analyzed histologic, apoptotic and gene expression changes by DNA microarray and quantitative PCR analysis. Results: Histologic analyses confirmed signs of CR in all lungs and positive labeling for apoptotic and anti-apoptotic markers. A total of 702 genes were regulated in the CR lungs: 317 genes were upregulated and 385 were downregulated. Significant changes for about 30 biologic processes, including regulation of the cytoskeleton, and 15 signaling pathways, such as adherens junctions, were observed. We found significantly increased mRNA expression of the Cldn5, Epas1, Tgfb1, Vegf, Selp1, Hsp27 and Igf1 genes. Conclusions: This is the first experimental study performed in an orthotopic model of LT using DNA microarray analysis. The individual genes, biologic process and pathways identified may represent novel targets that could be manipulated and contribute to the development of treatments capable of providing protection from CR. © 2012 International Society for Heart and Lung Transplantation. All rights reserved.-
dc.languageeng-
dc.relation.ispartofJournal of Heart and Lung Transplantation-
dc.sourceJournal of Heart and Lung Transplantation[ISSN 1053-2498],v. 31, p. 213-221-
dc.subject32 Ciencias médicas-
dc.subject321314 Cirugía de los trasplantes-
dc.subject.otherBronchiolitis Obliterans Syndrome-
dc.subject.otherGrowth-Factor-
dc.subject.otherAllograft-Rejection-
dc.subject.otherExpression-
dc.subject.otherRats-
dc.titleSearching for novel molecular targets of chronic rejection in an orthotopic experimental lung transplantation model-
dc.typeinfo:eu-repo/semantics/Article-
dc.typeArticle-
dc.identifier.doi10.1016/j.healun.2011.11.011-
dc.identifier.pmid22305384-
dc.identifier.scopus84856474019-
dc.identifier.scopus2-s2.0-84856474019-
dc.identifier.isi000300545100014-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.authorscopusid56072780900-
dc.contributor.authorscopusid42161321700-
dc.contributor.authorscopusid56223703300-
dc.contributor.authorscopusid57190093030-
dc.contributor.authorscopusid37041705700-
dc.contributor.authorscopusid8589373600-
dc.contributor.authorscopusid55236061500-
dc.contributor.authorscopusid16067215900-
dc.contributor.authorscopusid56698082300-
dc.contributor.authorscopusid6506731932-
dc.contributor.authorscopusid6602732739-
dc.contributor.authorscopusid57192669803-
dc.contributor.authorscopusid15830033900-
dc.contributor.authorscopusid6602240153-
dc.contributor.authorscopusid57103436000-
dc.contributor.authorscopusid6506777525-
dc.description.lastpage221-
dc.identifier.issue2-
dc.description.firstpage213-
dc.relation.volume31-
dc.investigacionCiencias de la Salud-
dc.type2Artículo-
dc.contributor.daisngid1685892-
dc.contributor.daisngid3214705-
dc.contributor.daisngid777033-
dc.contributor.daisngid3257911-
dc.contributor.daisngid7076641-
dc.contributor.daisngid27320-
dc.contributor.daisngid28407607-
dc.contributor.daisngid1466032-
dc.contributor.daisngid8993895-
dc.contributor.daisngid2034496-
dc.contributor.daisngid2333393-
dc.contributor.daisngid3685092-
dc.contributor.daisngid9019266-
dc.contributor.daisngid795544-
dc.identifier.external171918286-
dc.description.numberofpages9-
dc.utils.revision-
dc.contributor.wosstandardWOS:Santana-Rodriguez, N-
dc.contributor.wosstandardWOS:Garcia-Herrera, R-
dc.contributor.wosstandardWOS:Clavo, B-
dc.contributor.wosstandardWOS:Llontop, P-
dc.contributor.wosstandardWOS:Ponce-Gonzalez, MA-
dc.contributor.wosstandardWOS:Villar, J-
dc.contributor.wosstandardWOS:Lopez-Garcia, A-
dc.contributor.wosstandardWOS:Fiuza, MD-
dc.contributor.wosstandardWOS:Rodriguez-Bermejo, JC-
dc.contributor.wosstandardWOS:Garcia-Castellano, JM-
dc.contributor.wosstandardWOS:Machin, RP-
dc.contributor.wosstandardWOS:Ruiz-Caballero, JA-
dc.contributor.wosstandardWOS:Brito, Y-
dc.contributor.wosstandardWOS:Fernandez-Perez, L-
dc.date.coverdateFebrero 2012-
dc.identifier.ulpgc-
dc.contributor.buulpgcBU-MED-
dc.description.sjr2,639-
dc.description.jcr5,112-
dc.description.sjrqQ1-
dc.description.jcrqQ1-
dc.description.scieSCIE-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0003-2522-1064-
crisitem.author.orcid0000-0001-7802-465X-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameSantana Rodríguez,Norberto-
crisitem.author.fullNameClavo Varas,Bernardino-
crisitem.author.fullNameFiuza Pérez,Mª Dolores-
crisitem.author.fullNameFernández Pérez, Leandro Francisco-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

9
checked on Nov 17, 2024

WEB OF SCIENCETM
Citations

9
checked on Nov 17, 2024

Page view(s)

69
checked on Jul 20, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.